U.S. markets open in 7 hours 17 minutes
  • S&P Futures

    4,406.50
    -7.75 (-0.18%)
     
  • Dow Futures

    34,965.00
    -69.00 (-0.20%)
     
  • Nasdaq Futures

    15,098.75
    -19.00 (-0.13%)
     
  • Russell 2000 Futures

    2,205.60
    -7.80 (-0.35%)
     
  • Crude Oil

    72.16
    +0.25 (+0.35%)
     
  • Gold

    1,795.00
    -4.20 (-0.23%)
     
  • Silver

    25.28
    -0.03 (-0.13%)
     
  • EUR/USD

    1.1799
    -0.0008 (-0.07%)
     
  • 10-Yr Bond

    1.2760
    0.0000 (0.00%)
     
  • Vix

    17.58
    +0.38 (+2.21%)
     
  • GBP/USD

    1.3815
    -0.0009 (-0.07%)
     
  • USD/JPY

    110.1950
    -0.1800 (-0.16%)
     
  • BTC-USD

    37,186.45
    -1,372.45 (-3.56%)
     
  • CMC Crypto 200

    880.65
    -34.84 (-3.81%)
     
  • FTSE 100

    7,025.43
    -2.15 (-0.03%)
     
  • Nikkei 225

    27,936.37
    +103.08 (+0.37%)
     

Sangamo Therapeutics Announces Participation at Jefferies Healthcare Conference

·1 min read

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will participate in a fireside chat at the Jefferies Healthcare Conference on Friday, June 4th at 11am Eastern Time.

The virtual session will be webcast live and may be accessed on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo Therapeutics website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, cell therapy, and genome engineering. For more information about Sangamo, visit www.sangamo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210521005024/en/

Contacts

Investor Relations & Media Inquiries
Aron Feingold
628.252.7494
afeingold@sangamo.com